$HZNP News Thursday’s biggest gaining and decl
Post# of 72749
Posted On: 01/07/2014 2:33:24 PM
$HZNP News
Thursday’s biggest gaining and declining stocks 3:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 8:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 8:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 5:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 9:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 11:00 a.m. July 28, 2011 - MarketWatch.com
A Classic Melt-Up 4:25 p.m. Dec. 20, 2013 - RealMoney.com
A Little Follow-Through 10:25 a.m. Dec. 20, 2013 - RealMoney.com
A Very Shallow Pullback 4:20 p.m. Dec. 19, 2013 - RealMoney.com
High Anxiety 1:15 p.m. Dec. 19, 2013 - RealMoney.com
Top Insider Trades: VRX HZNP SEAS LNBB 9:15 a.m. Dec. 18, 2013 - TheStreet.com
Earnings Estimates Moving Higher for Horizon Pharma (HZNP): Time to Buy? - Tale of the Tape 8:40 a.m. Dec. 13, 2013 - Zacks.com
Horizon Pharma (HZNP) In A Perilous Reversal 1:45 p.m. Dec. 2, 2013 - TheStreet.com
The Slow-Motion Rally Rolls On 4:49 p.m. Nov. 22, 2013 - RealMoney.com
Comatose Action 10:47 a.m. Nov. 22, 2013 - RealMoney.com
Horizon Pharma rallies again following Cramer comment 2:31 p.m. Nov. 21, 2013 - Seeking Alpha
Jim Cramer: Buy Fluor, Home Depot, and These 2 Stocks 9:56 a.m. Nov. 21, 2013 - Wall St. Cheat Sheet
Cramer's Lightning Round - Halcon Is Not Bringing Home The Bacon (11/20/13) 7:34 a.m. Nov. 21, 2013 - Seeking Alpha
'Mad Money' Lightning Round: F5 Networks Is a Great Stock 6:00 a.m. Nov. 21, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Forget the Fed's Old News 8:19 p.m. Nov. 20, 2013 - TheStreet.com
Stock To Watch: Horizon Pharma (HZNP) In Perilous Reversal 10:00 a.m. Nov. 20, 2013 - TheStreet.com
Horizon: Hold Or Take Profit Now? 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
At a Loss 4:23 p.m. Nov. 19, 2013 - RealMoney.com
Horizon Pharma's CEO Presents at Agreement to Acquire U.S. Rights to Vimovo Conference (Transcript) 3:50 p.m. Nov. 19, 2013 - Seeking Alpha
Horizon Pharma: Speculative Small Cap Moving On News 3:09 p.m. Nov. 19, 2013 - Seeking Alpha
Downright Disgusted 1:39 p.m. Nov. 19, 2013 - RealMoney.com
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Today - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:29 a.m. Jan. 2, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 19, 2013 - Marketwire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 5, 2013 - Marketwire
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 8:00 a.m. Dec. 2, 2013 - PR Newswire
Horizon Pharma to Present at the Piper Jaffray 25th Annual Healthcare Conference 7:30 a.m. Nov. 26, 2013 - Marketwire
Strategic Acquisitions, New Drug Applications, Licensing Agreements, and Financial Results - Research Report on Horizon Pharma, NPS Pharmaceuticals, Spherix, Evoke Pharma, and POZEN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
HZNP, FB, GRPN and IPCI added to NASDAQ Active Stock Watch List at GSR 10:10 a.m. Nov. 19, 2013 - ACCESSWIRE
POZEN Announces U.S. Rights for VIMOVO(R) to Be Acquired by Horizon Pharma USA, Inc. 6:15 a.m. Nov. 19, 2013 - BusinessWire
Horizon Pharma Announces Pricing of $150 Million of 5.00% Convertible Senior Notes 6:05 a.m. Nov. 19, 2013 - Marketwire
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance 6:00 a.m. Nov. 19, 2013 - Marketwire
Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax 8:00 a.m. Nov. 13, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Nov. 12, 2013 - Marketwire
OXBT, HZNP, PPHM and NWBO added to NASDAQ Healthcare Stock Watch List at GSR 10:35 a.m. Nov. 11, 2013 - ACCESSWIRE
Horizon Pharma and Mundipharma Sign Exclusive Agreement to Commercialize LODOTRA(R) in the Middle East and Africa 7:30 a.m. Nov. 11, 2013 - Marketwire
Horizon Pharma Announces Third Quarter 2013 Financial Results, Reports Net Revenue of $26.2 Million 6:30 a.m. Nov. 8, 2013 - Marketwire
Thursday’s biggest gaining and declining stocks 3:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 8:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 8:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 5:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 9:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 11:00 a.m. July 28, 2011 - MarketWatch.com
A Classic Melt-Up 4:25 p.m. Dec. 20, 2013 - RealMoney.com
A Little Follow-Through 10:25 a.m. Dec. 20, 2013 - RealMoney.com
A Very Shallow Pullback 4:20 p.m. Dec. 19, 2013 - RealMoney.com
High Anxiety 1:15 p.m. Dec. 19, 2013 - RealMoney.com
Top Insider Trades: VRX HZNP SEAS LNBB 9:15 a.m. Dec. 18, 2013 - TheStreet.com
Earnings Estimates Moving Higher for Horizon Pharma (HZNP): Time to Buy? - Tale of the Tape 8:40 a.m. Dec. 13, 2013 - Zacks.com
Horizon Pharma (HZNP) In A Perilous Reversal 1:45 p.m. Dec. 2, 2013 - TheStreet.com
The Slow-Motion Rally Rolls On 4:49 p.m. Nov. 22, 2013 - RealMoney.com
Comatose Action 10:47 a.m. Nov. 22, 2013 - RealMoney.com
Horizon Pharma rallies again following Cramer comment 2:31 p.m. Nov. 21, 2013 - Seeking Alpha
Jim Cramer: Buy Fluor, Home Depot, and These 2 Stocks 9:56 a.m. Nov. 21, 2013 - Wall St. Cheat Sheet
Cramer's Lightning Round - Halcon Is Not Bringing Home The Bacon (11/20/13) 7:34 a.m. Nov. 21, 2013 - Seeking Alpha
'Mad Money' Lightning Round: F5 Networks Is a Great Stock 6:00 a.m. Nov. 21, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Forget the Fed's Old News 8:19 p.m. Nov. 20, 2013 - TheStreet.com
Stock To Watch: Horizon Pharma (HZNP) In Perilous Reversal 10:00 a.m. Nov. 20, 2013 - TheStreet.com
Horizon: Hold Or Take Profit Now? 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
At a Loss 4:23 p.m. Nov. 19, 2013 - RealMoney.com
Horizon Pharma's CEO Presents at Agreement to Acquire U.S. Rights to Vimovo Conference (Transcript) 3:50 p.m. Nov. 19, 2013 - Seeking Alpha
Horizon Pharma: Speculative Small Cap Moving On News 3:09 p.m. Nov. 19, 2013 - Seeking Alpha
Downright Disgusted 1:39 p.m. Nov. 19, 2013 - RealMoney.com
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Today - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:29 a.m. Jan. 2, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 19, 2013 - Marketwire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 5, 2013 - Marketwire
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 8:00 a.m. Dec. 2, 2013 - PR Newswire
Horizon Pharma to Present at the Piper Jaffray 25th Annual Healthcare Conference 7:30 a.m. Nov. 26, 2013 - Marketwire
Strategic Acquisitions, New Drug Applications, Licensing Agreements, and Financial Results - Research Report on Horizon Pharma, NPS Pharmaceuticals, Spherix, Evoke Pharma, and POZEN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
HZNP, FB, GRPN and IPCI added to NASDAQ Active Stock Watch List at GSR 10:10 a.m. Nov. 19, 2013 - ACCESSWIRE
POZEN Announces U.S. Rights for VIMOVO(R) to Be Acquired by Horizon Pharma USA, Inc. 6:15 a.m. Nov. 19, 2013 - BusinessWire
Horizon Pharma Announces Pricing of $150 Million of 5.00% Convertible Senior Notes 6:05 a.m. Nov. 19, 2013 - Marketwire
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance 6:00 a.m. Nov. 19, 2013 - Marketwire
Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax 8:00 a.m. Nov. 13, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Nov. 12, 2013 - Marketwire
OXBT, HZNP, PPHM and NWBO added to NASDAQ Healthcare Stock Watch List at GSR 10:35 a.m. Nov. 11, 2013 - ACCESSWIRE
Horizon Pharma and Mundipharma Sign Exclusive Agreement to Commercialize LODOTRA(R) in the Middle East and Africa 7:30 a.m. Nov. 11, 2013 - Marketwire
Horizon Pharma Announces Third Quarter 2013 Financial Results, Reports Net Revenue of $26.2 Million 6:30 a.m. Nov. 8, 2013 - Marketwire
(0)
(0)